Navigation Links
DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Date:8/19/2007

SOMERSET, N.J., Aug. 9 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. ("DOV" or the "Company") (Pink Sheets: DOVP.PK) today announced Phase Ib results for DOV 21,947, its lead triple reuptake inhibitor ("TRIP") for the treatment of depression and obesity. Preliminary analysis of the study results indicates DOV 21,947 was safe and well-tolerated at the doses examined and produced a significant decline in plasma triglyceride levels. The Company intends to initiate a Phase II study of DOV 21,947 for the treatment of depression in the fourth quarter of this year.

"Prior studies with DOV 21,947 at up to 100 mg per day demonstrated the safety and tolerability of this compound over dosing periods of up to ten days. The goal of this Phase Ib study was to confirm DOV 21,947's safety and tolerability over an eight-week period at escalating doses of up to 150 mg per day. These data give us added confidence in the drug's safety and tolerability in preparation for our upcoming Phase II trial in patients with major depressive disorder. The significant reductions in plasma triglyceride levels observed during the conduct of this study are consistent with preclinical evidence that DOV 21,947 is able to produce a significant and sustained reduction in both triglyceride levels and body weight in animal models of obesity. These findings underscore the therapeutic versatility of triple reuptake inhibitors such as DOV 21,947," said Dr. Phil Skolnick, President and Chief Scientific Officer of DOV.

This double-blind, placebo-controlled Phase Ib study enrolled 46 male and female subjects. Following a one-week placebo run-in, subjects received either escalating daily doses of 50 mg, 100 mg and 150 mg of DOV 21,947 (31 subjects) or placebo (15 subjects), for a total of eight weeks. The study demonstrated that DOV 21,947 was safe and well-tolerated in this dose range with no reported serious adverse events. The proportion of patients with treatment emergent adverse event
'/>"/>

SOURCE DOV Pharmaceutical, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... KNOXVILLE, Tenn. , May 23, 2013 /PRNewswire/ ... of 24-hour nurse triage and nurse advice lines, ... 10-person committee, comprising physician, nursing and administrative leaders, ... providing safe, quality and cost-effective services for hospital ... "As our national healthcare system evolves, it,s imperative ...
(Date:5/23/2013)...  The need to add tissue preserving therapies ... prominently at the 108 th Annual Meeting ... Diego.  According to SonaCare Medical, a leader in ... the need for image-guided technologies to better identify ... minimally invasive ablative treatments, was addressed in the ...
(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6TMA Launches Physician Services Organization for Patient Care 2TMA Launches Physician Services Organization for Patient Care 3TMA Launches Physician Services Organization for Patient Care 4
... 24, 2011 Cadence, Inc., a leading manufacturer of ... markets, announced yesterday that it will invest nearly $16 ... allow Cadence to expand its capabilities in the medical ... significant new business. "This major expansion ...
... 2011 For the fifth straight year, Elekta has ... Clinical Oncology (ASCO) Electronic Health Records (EHR) Lab, June ... will be Elekta,s MOSAIQ® Oncology Information System, the first ... under the federal government,s HITECH Act. MOSAIQ is fully ...
Cached Medicine Technology:Cadence, Inc. Announces Major Expansion 2Elekta to Feature Certified MOSAIQ EHR at Electronic Health Records Lab During the 2011 ASCO Annual Meeting 2
(Date:5/24/2013)... 24, 2013 Today marks the launch ... Itinerary Builder. , The redesigned and enhanced Itinerary ... vacation itineraries on their computer or mobile device that ... interactive tool allows users to fill in their date ... and select their choice of vacation packages, accommodations, restaurants, ...
(Date:5/24/2013)... 24, 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html ... latest update involving allegations that the use of ... can allegedly cause potentially fatal irregular heart ... May 17, 2013* that Health Canada has joined ... that Zithromax can cause abnormal changes in the ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Scott Ryan ... brother, Troy Tischler, lose 200 lbs. of fat in ... Tischler teach his younger brother the importance of exercising. ... diet. By sticking to these 7 rules of healthy ... loss goals can be accomplished. , 1.    Find a distraction ...
(Date:5/24/2013)... Psoriasis treatment cream has been released online for ... registered company is now offering its natural solution to ... infected skin. , Dermasis has launched its new psoriasis ... cream is designed to offer immediate relief to those ... red skin often caused by psoriasis outbreaks. This new ...
(Date:5/23/2013)... FL (PRWEB) May 24, 2013 ... the Cellulite Whisperer line, with a ... for Summer Sale" includes two proprietary products, the ... Whisperer® Lotion . , Purchasers receive a report ... , "The Gel has a wonderful grapefruit scent," ...
Breaking Medicine News(10 mins):Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4Health News:Dermasis Psoriasis Treatment Cream for Men and Women Released Online at HealthCareSupplementz.com 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2
... Consumers need to know what,s ... in their seafood thanks to the Gulf Oil Spill. But in the long term, thoughts will ... putting consumers on notice that their new supplements are unique. , ... (PRWEB) June 14, 2010 -- The BP Gulf Oil Spill may put ...
... the Ecole Polytechnique Fdrale de Lausanne (EPFL) in Switzerland ... bladder become fluorescent and are more easily discoverable under ... the technique already in practice in Europe for ... is commercialized by Photocure and GE Healthcare as the ...
... ... out tasty Mediterranean diet recipes for home use across the world like never before. ... (PRWEB) June 14, 2010 -- ... most healthy) diets in the world. It,s origin is taken from the sixteen or so ...
... ... of premium dietary supplements, announces the release of their new sleep health supplement, ... ... direct-to-consumer provider of premium dietary supplements, announces the release of their new sleep ...
... advantage over uninsured or Medicaid patients, research shows , ... rectal cancer patients are more likely to die within ... due to disparities in treatment and cancer stage at ... reduced through health care reform, the researchers noted in ...
... Alabama at Birmingham (UAB) Comprehensive Cancer Center and UAB ... the U.S. Department of Defense Breast Cancer Research Program ... treatment encourage cancer,s spread to other parts of the ... altered genetic material (DNA) left in the body after ...
Cached Medicine News:Health News:Liberty Health shows how the BP Oil Spill may draw attention to the purity of the company's newly released Nutritional Supplements. 2Health News:Liberty Health shows how the BP Oil Spill may draw attention to the purity of the company's newly released Nutritional Supplements. 3Health News:Liberty Health shows how the BP Oil Spill may draw attention to the purity of the company's newly released Nutritional Supplements. 4Health News:Early detection of cancer: The FDA approves procedure discovered by EPFL researchers 2Health News:Monthly Release of Mediterranean Diet Weight Loss Recipes 2Health News:Purity Products Releases Ultimate Sleep Plus Melatonin 2Health News:Health Plan May Influence 5-Year Rectal Cancer Survival 2Health News:Are dead cancer cells feeding cancer's spread? 2
... Multifunctional instrumentation, capable of comminution, ... by means of ultra-sonic energy. ... organs, and, in particular, parenchymatous ... of tissue-selection and non-traumatic preparation ...
... system is the recognized world leader, ... superior tactile feedback and exceptional visualization ... surgical modality combines tissue fragmentation, irrigation, ... performance in procedures requiring precise, selective ...
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 7.0 mm and length 7.5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Deflected large type, opening width 8.0 mm and length 7.5 mm....
Medicine Products: